The guidance on digital and decentralised clinical trials (DCT) has been updated

The update aligns with the common EU guidance and includes supplementary information relevant to the Danish context, including a section on cross-border participation.

The Danish guidance does not introduce any additional requirements beyond the EU framework.

The update builds on input from our dialogue forum on decentralised trials, established in collaboration with Trial Nation, and from the ongoing contributions from key stakeholders in both the private and public sectors with experience in decentralised clinical trials.

Read more here and find both guidelines in the blue box on the page.